Leading Innovation and Developing 21st Century Medicines
PARTNERSHIPS
We believe in the power of partnerships. We believe that collaboration is key to accelerating the development of innovative and life-saving therapies. Through partnerships, collaboration and strategic alliances we are developing safe and effective therapies for some of the most debilitating diseases. Leveraging our library of novel and First-in-Class of Peptide Conjugate Nanosystems (PCN)TM and innovative proprietary technology platforms we are developing novel therapies for central nervous system diseases and other disorders by delivering next generation and precision advanced therapies.
DELIVERING LIFE SAVING THERAPIES,
OVERCOMING BARRIERS
Our approach is different. We have designed and optimised effective and versatile therapeutic and delivery platform technologies along with a library of new class of small molecules/peptide conjugates.
If you are interested in partnering with us to develop the next generation of 21st century therapies, contact us today.
Organisations Funding and Supporting Us
We have established an international network of expanding 8 collaborations across academia, industry and patient advocacy groups. We believe in the power of partnerships and working with those who share our vision and commitment to patients.
